The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

Your go-to for B2B Marketing Training and Consulting backed by data science, psychology ... Want to reach more people and make your brand a trusted authority on social media? Then amplify your brand ...